Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",27488,1361,0.81 [0.73-0.90],7.335404787018194e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Candidiasis,27798,481,0.83 [0.70-0.99],0.0416011539231686
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,26934,3562,0.90 [0.84-0.96],0.0017544355053286
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),27166,2935,0.86 [0.80-0.93],0.0001081522648092
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,27504,1396,0.86 [0.77-0.95],0.0041170694377231
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,25905,836,0.81 [0.70-0.92],0.0014979584477483
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,25062,980,0.75 [0.66-0.84],2.2253621975557827e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,25075,267,0.77 [0.61-0.97],0.0250859530897151
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,19504,1710,0.79 [0.72-0.87],1.3156461192064783e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,27737,1629,0.90 [0.81-0.99],0.0335934293757414
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Mycoses,27865,548,0.82 [0.70-0.97],0.0193738111806413
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,27094,967,0.74 [0.66-0.84],6.737840088423641e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27808,923,0.82 [0.72-0.93],0.002779096551434
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27693,808,0.82 [0.72-0.94],0.0055747583131919
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,26477,350,0.77 [0.63-0.95],0.013832617090034
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27850,164,0.71 [0.54-0.92],0.0101104551231501
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],27766,80,0.61 [0.44-0.85],0.0032457278960901
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,Benign neoplasm: Rectum,27869,289,0.75 [0.61-0.93],0.0082597983596557
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",22754,97,0.66 [0.48-0.90],0.008338630430198
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,26896,3045,0.84 [0.78-0.90],1.4043283281238886e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,27329,1575,0.78 [0.71-0.86],2.218322299781643e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,27329,1575,0.78 [0.71-0.86],2.218322299781643e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,27511,1300,0.84 [0.75-0.93],0.0013889393940008
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,27283,53,0.60 [0.40-0.91],0.0150072889041968
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,26348,137,0.66 [0.50-0.87],0.0034203658990028
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,22468,261,0.63 [0.51-0.77],8.376039996983372e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,26466,67,0.51 [0.37-0.71],6.544167165523787e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,25240,251,0.74 [0.59-0.94],0.0117872145697016
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,27256,295,1.41 [1.06-1.88],0.0185964826383117
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,24700,1934,0.90 [0.82-0.99],0.0289600813343003
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",22267,60,0.52 [0.37-0.73],0.0001544523831695
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,22498,291,0.68 [0.55-0.83],0.0002059540710366
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,25414,3207,0.89 [0.82-0.96],0.0015890649097568
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,22414,207,0.64 [0.51-0.81],0.0001574567331418
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,22757,550,0.73 [0.63-0.86],0.0001146339034212
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27822,379,0.78 [0.64-0.94],0.0089263443824825
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,27631,188,0.74 [0.57-0.97],0.0291802182357021
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",22262,55,0.57 [0.39-0.83],0.0038976583885884
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,22423,216,0.68 [0.53-0.87],0.0025779992747612
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,22428,221,0.64 [0.51-0.81],0.0002081373855512
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",22749,542,0.79 [0.67-0.94],0.0068814739105742
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,22846,639,0.73 [0.63-0.84],1.781760420960175e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,22785,578,0.71 [0.61-0.83],6.88656664663477e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,27005,4798,0.86 [0.81-0.91],1.985803004371462e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,27724,2120,0.81 [0.74-0.88],3.342887157780849e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",27729,2119,0.81 [0.74-0.89],5.052408572703082e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,24733,80,0.62 [0.44-0.88],0.0066520746352922
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,27510,1621,0.88 [0.79-0.97],0.0084760931016855
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",23767,1560,0.72 [0.66-0.79],2.875243268400212e-12
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",22480,273,0.68 [0.55-0.83],0.0001997301361632
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,27428,1509,0.89 [0.80-0.99],0.0334625315979175
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,22956,749,0.84 [0.72-0.97],0.0214725155810872
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27824,235,0.78 [0.61-1.00],0.0457487075134476
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),26896,57,0.56 [0.37-0.83],0.0041537184494421
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Angina pectoris,26361,902,0.87 [0.76-0.99],0.0409962820493336
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Aortic aneurysm,26941,102,0.62 [0.45-0.85],0.0032003359929712
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,26872,33,0.50 [0.31-0.78],0.0025395843256418
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",26993,154,0.73 [0.54-0.99],0.0439087235845063
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,18162,1520,0.79 [0.72-0.87],1.2179118121706957e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,AV-block,24440,248,0.70 [0.56-0.88],0.0020395831685048
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Cardiac arrest,16774,132,0.63 [0.48-0.82],0.0007838971729617
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Conduction disorders,24939,747,0.78 [0.68-0.89],0.0003793588468022
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,26991,1544,0.86 [0.77-0.95],0.0030606760196287
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,25108,7403,0.90 [0.86-0.95],4.1121248561567184e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Endocarditis,24255,63,0.62 [0.42-0.92],0.0172609760598667
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27827,875,0.67 [0.60-0.75],1.2416942046019305e-11
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Hypertension,25743,6258,0.88 [0.84-0.93],2.136346860958513e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Hypertension, essential",25755,6270,0.88 [0.84-0.93],1.6454283354983272e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Hypotension,27782,1135,0.82 [0.73-0.92],0.0005787482397925
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",27193,1734,0.88 [0.80-0.97],0.0107762376580942
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Left bundle-branch block,24496,304,0.72 [0.58-0.88],0.0012987054584763
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27700,618,0.82 [0.70-0.96],0.0120960042509328
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",25955,496,0.77 [0.65-0.90],0.0016644963404439
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27901,88,0.62 [0.45-0.86],0.0040004437200136
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,26905,66,0.53 [0.38-0.75],0.0003290982926049
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,24352,160,0.71 [0.54-0.94],0.0178023775256042
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,26292,168,0.64 [0.50-0.82],0.0004376899788598
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,25023,831,0.76 [0.66-0.86],3.058377683222038e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27351,512,0.68 [0.58-0.78],1.5128640416694718e-07
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27342,325,0.71 [0.58-0.87],0.0009235411701981
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",27166,556,0.81 [0.69-0.95],0.0108991899292451
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16937,295,0.67 [0.56-0.80],1.4387566435432008e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Peripheral artery disease,27106,281,0.69 [0.56-0.85],0.0004876024791454
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27847,602,0.78 [0.67-0.91],0.001303832832708
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Right bundle-branch block,24421,229,0.75 [0.59-0.95],0.0165882132654254
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27334,317,0.70 [0.57-0.85],0.0005002869517447
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,26851,97,0.62 [0.45-0.86],0.0035812207395714
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27880,225,0.67 [0.54-0.83],0.0002281267617342
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",24793,1889,0.88 [0.81-0.97],0.0096221310933719
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,Any mental disorder,27303,4399,0.89 [0.84-0.95],0.0002213848099498
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27848,268,0.72 [0.58-0.88],0.0018026650574656
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",24910,2006,0.91 [0.83-1.00],0.0399941865151771
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",24314,1410,0.84 [0.75-0.93],0.0011465353161316
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter V Mental and behavioural disorders,Vascular dementia,27412,103,0.70 [0.50-0.99],0.0447280968680026
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Alzheimer disease,27927,367,1.31 [1.02-1.69],0.0336095481932816
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",19048,60,2.44 [1.20-4.92],0.0131936966030059
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Bell's palsy,25725,87,0.61 [0.44-0.83],0.0021237655849097
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,27503,1382,0.84 [0.76-0.94],0.0017487957306309
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,27877,523,0.83 [0.70-0.99],0.0341043890815087
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Falls/tendency to fall,27278,2958,0.91 [0.84-0.98],0.0116530707083113
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Generalized epilepsy,27551,47,0.63 [0.40-0.98],0.0386693078334298
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Migraine,26647,526,0.83 [0.70-0.98],0.0297033816298473
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27811,472,0.78 [0.66-0.93],0.0049092788208901
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other facial nerve disorders,25735,97,0.62 [0.45-0.84],0.001948921665409
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Other sleep disorders,26536,415,0.82 [0.67-1.00],0.0477493045958313
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Sleep apnoea,27745,328,0.75 [0.61-0.93],0.0096021217156526
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,27927,371,1.31 [1.02-1.68],0.0353999103825454
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,26782,49,0.58 [0.39-0.86],0.006758945182487
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,27287,189,1.47 [1.03-2.10],0.036127469685871
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,27895,56,0.63 [0.42-0.96],0.0334165454191822
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,27631,70,0.62 [0.44-0.88],0.007788007165524
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,27824,826,0.86 [0.75-0.99],0.0356384965341836
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,27564,566,0.82 [0.70-0.97],0.0179145953246118
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Bronchiectasis,24157,416,0.77 [0.64-0.92],0.0037983241742059
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,26758,3017,0.90 [0.84-0.97],0.0064346390440647
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",27750,1080,0.81 [0.72-0.92],0.000733516942232
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,25800,5243,0.88 [0.84-0.94],1.9529174167344926e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Early onset COPD,26993,323,0.75 [0.61-0.92],0.0062238412613392
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Emphysema,24021,280,0.76 [0.58-0.98],0.0315523574837365
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,26266,236,0.68 [0.55-0.84],0.0004831607107577
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Influenza and pneumonia,27730,1689,0.76 [0.69-0.83],3.15902242968063e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Interstitial lung disease,26307,277,0.68 [0.56-0.84],0.0002452785860144
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Later onset COPD,26992,757,0.85 [0.73-0.99],0.0395758316816183
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27694,937,0.84 [0.74-0.95],0.0067102002147625
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Other diseases of pleura,27733,1780,0.76 [0.69-0.83],8.74682519086397e-10
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27845,353,0.68 [0.57-0.81],2.442147756589148e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,27836,1198,0.75 [0.67-0.83],8.11135625118118e-08
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Pleural effusion,26819,866,0.76 [0.67-0.86],1.600599528432895e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",27494,1453,0.74 [0.67-0.82],1.393320206041579e-09
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,27890,204,0.76 [0.59-0.98],0.0356680456006792
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Pneumothorax,26046,93,0.67 [0.47-0.94],0.0216259119772795
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Pulmonary oedema,27557,65,0.57 [0.39-0.83],0.003472508079913
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27669,912,0.84 [0.74-0.96],0.0093341881280547
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Alcoholic liver disease,27031,35,0.53 [0.34-0.83],0.0061159489445952
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diseases of liver,27826,830,0.87 [0.75-1.00],0.0464106267402237
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diseases of the digestive system,27622,1438,0.87 [0.78-0.96],0.0073773718636901
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",27041,1628,0.85 [0.77-0.94],0.0017782455093396
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,23126,3275,0.90 [0.84-0.96],0.002849064022288
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Gastric ulcer,21204,353,0.78 [0.64-0.95],0.0133044396546811
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,21330,479,0.81 [0.68-0.96],0.0170343962431439
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,GI-bleeding,27345,1161,0.82 [0.73-0.92],0.0006076641419007
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Impaction of intestines,19916,65,0.65 [0.44-0.95],0.0268171850237629
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,27002,1133,0.89 [0.79-1.00],0.0473632926619427
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Oesophageal obstruction,21014,163,0.70 [0.54-0.90],0.0062768973764523
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,25720,307,0.79 [0.63-0.99],0.0366215547497398
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of intestine,21476,1625,0.89 [0.80-0.98],0.0186003274495221
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of intestines,25702,5851,0.94 [0.89-0.99],0.0186238588883514
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,27364,1180,0.82 [0.74-0.92],0.0007238791858758
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Ulcerative colitis,26042,173,0.76 [0.58-1.00],0.0465704236530324
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,20045,194,0.68 [0.53-0.86],0.0014480124177894
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XI Diseases of the digestive system,Volvulus,19939,88,0.69 [0.49-0.98],0.0358347849783785
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27383,648,0.77 [0.67-0.90],0.0006327306735577
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,25948,347,0.68 [0.56-0.81],2.839450321847825e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,26295,3231,0.85 [0.79-0.91],3.499798984949332e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27601,866,0.79 [0.69-0.90],0.0003038442446989
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27693,169,0.73 [0.56-0.96],0.0267623945193677
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,27227,1626,0.85 [0.77-0.94],0.0013160760108581
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27839,315,0.73 [0.60-0.89],0.0014561924071912
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27764,240,0.73 [0.58-0.91],0.0058984381869411
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",25806,205,0.64 [0.51-0.81],0.0001994210974604
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,23830,127,0.59 [0.46-0.75],1.6515676044396686e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,25358,6510,0.92 [0.87-0.97],0.001151461752311
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,23933,5085,0.91 [0.86-0.96],0.0014490829199829
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",23915,120,0.68 [0.50-0.92],0.0112202687302674
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,23470,8277,0.91 [0.87-0.96],0.0001026322857524
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,25017,144,0.70 [0.53-0.92],0.0118208947358256
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,26892,3097,0.91 [0.85-0.98],0.0136825757641719
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,24092,389,0.79 [0.65-0.95],0.0144919604084242
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,20760,1912,0.85 [0.78-0.93],0.0006187495812401
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,19079,231,0.67 [0.52-0.85],0.0013250092128406
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27914,228,0.70 [0.55-0.89],0.0032098889816712
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,24524,729,0.84 [0.73-0.97],0.0213553487435783
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,27434,2561,0.83 [0.77-0.90],1.6272664993341716e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,26715,1842,0.81 [0.75-0.89],3.362423886413199e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27725,615,0.79 [0.68-0.92],0.0029566473585701
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,21959,3111,0.84 [0.78-0.90],1.4728683550956633e-06
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),19081,233,0.77 [0.60-0.97],0.02958794785488
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,21441,2593,0.90 [0.83-0.97],0.0087490548359642
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",25220,1517,0.88 [0.79-0.97],0.0141913746471196
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,20882,2034,0.91 [0.83-1.00],0.0395328071475422
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27361,515,0.79 [0.67-0.93],0.0049109734734357
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27740,595,0.81 [0.69-0.95],0.0094043473906234
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,27898,70,0.61 [0.43-0.86],0.0054805166803218
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",18925,77,0.66 [0.45-0.97],0.0333236748500192
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,21549,2701,0.87 [0.80-0.94],0.0003403393153714
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,19713,865,0.86 [0.75-0.98],0.0276867502775664
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,19466,618,0.76 [0.66-0.89],0.0004748730987413
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,21560,86,0.60 [0.44-0.82],0.0012511459513881
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",27904,76,0.62 [0.44-0.87],0.0054837295919647
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,24353,650,0.79 [0.69-0.92],0.0019195869262224
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],27012,166,0.61 [0.49-0.77],1.803435591960509e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,26584,2881,0.91 [0.84-0.98],0.0168239063139693
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,25597,1802,0.88 [0.80-0.97],0.0115712845006024
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27076,230,0.64 [0.53-0.79],2.04996649154504e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Acute renal failure,26825,1289,0.80 [0.72-0.89],5.0209467863065896e-05
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,27207,111,0.69 [0.51-0.95],0.0211747200558925
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21833,1028,0.83 [0.74-0.93],0.0017473316010347
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,21738,5171,0.92 [0.87-0.97],0.0040863236522586
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,25414,216,0.73 [0.57-0.92],0.0079036709666806
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,23306,2501,0.91 [0.84-0.99],0.0220809046809415
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,26656,2284,0.88 [0.81-0.96],0.0028660046402553
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,26328,1956,0.85 [0.78-0.93],0.0002728221185109
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,25466,268,0.72 [0.58-0.89],0.002002804132515
ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,27726,2528,0.88 [0.81-0.96],0.0026083733676765
